tiprankstipranks
Trending News
More News >

Twist Bioscience price target lowered to $50 from $58 at Guggenheim

Guggenheim lowered the firm’s price target on Twist Bioscience (TWST) to $50 from $58 and keeps a Buy rating on the shares. The firm adjusted models and forecasts for several companies in its Diagnostics and Life Sciences Tools coverage to reflect recent updates from the companies after meetings with management teams.

Don’t Miss TipRanks’ Half Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1